BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 34119934)

  • 1. Multi-disciplinary approach for the management of non-metastatic non-small cell lung cancer in the Middle East and Africa: Expert panel recommendations.
    Göker E; Altwairgi A; Al-Omair A; Tfayli A; Black E; Elsayed H; Selek U; Koegelenberg C
    Lung Cancer; 2021 Aug; 158():60-73. PubMed ID: 34119934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology.
    J Clin Oncol; 1997 Aug; 15(8):2996-3018. PubMed ID: 9256144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification and implementation of NCCN guidelines on non-small cell lung cancer in the Middle East and North Africa region.
    Jazieh AR; Bamefleh H; Demirkazik A; Gaafar RM; Geara FB; Javaid M; Khader J; Khodadad K; Omar W; Saadeddin A; Sabe HA; Shadmehr MB; El Sherif A; Uddin N; Jahanzeb M; Ettinger D;
    J Natl Compr Canc Netw; 2010 Jul; 8 Suppl 3():S16-21. PubMed ID: 20697125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Approach to the non-operative management of patients with stage II non-small cell lung cancer (NSCLC): A survey of Canadian medical and radiation oncologists.
    Dudani S; Leighl NB; Ho C; Pantarotto JR; Zhu X; Zhang T; Wheatley-Price P
    Lung Cancer; 2016 Apr; 94():74-80. PubMed ID: 26973210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical management of stage III non-small cell lung cancer in India: An expert consensus statement.
    Batra U; Prabhash K; Agarwal JP; Darlong L; Munshi A; Penumadu P; Thangakunam B; Bansal A
    Asia Pac J Clin Oncol; 2023 Dec; 19(6):606-617. PubMed ID: 36815621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group.
    Logan DM; Lochrin CA; Darling G; Eady A; Newman TE; Evans WK
    Cancer Prev Control; 1997 Dec; 1(5):366-78. PubMed ID: 9765759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relevance of multi-disciplinary team approach in diagnosis and management of Stage III NSCLC.
    Batra U; Munshi A; Kabra V; Momi G
    Indian J Cancer; 2022 Mar; 59(Supplement):S46-S55. PubMed ID: 35343190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
    Howington JA; Blum MG; Chang AC; Balekian AA; Murthy SC
    Chest; 2013 May; 143(5 Suppl):e278S-e313S. PubMed ID: 23649443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of locally advanced non-small cell lung cancer in the modern era: A national Italian survey on diagnosis, treatment and multidisciplinary approach.
    Bruni A; Giaj-Levra N; Ciammella P; Maragna V; Ferrari K; Bonti V; Grossi F; Greco S; Greco C; Borghetti P; Franceschini D; Capelletto E; Perna M; Banna G; Vagge S; Baldini E; Bria E; Botti A; Tiseo M; Paci M; Taraborrelli M; Poletti V; Granone P; Ricardi U; Novello S; Scotti V
    PLoS One; 2019; 14(11):e0224027. PubMed ID: 31721773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-small cell lung cancer, version 1.2015.
    Ettinger DS; Wood DE; Akerley W; Bazhenova LA; Borghaei H; Camidge DR; Cheney RT; Chirieac LR; D'Amico TA; Demmy TL; Dilling TJ; Govindan R; Grannis FW; Horn L; Jahan TM; Komaki R; Kris MG; Krug LM; Lackner RP; Lanuti M; Lilenbaum R; Lin J; Loo BW; Martins R; Otterson GA; Patel JD; Pisters KM; Reckamp K; Riely GJ; Rohren E; Schild S; Shapiro TA; Swanson SJ; Tauer K; Yang SC; Gregory K; Hughes M
    J Natl Compr Canc Netw; 2014 Dec; 12(12):1738-61. PubMed ID: 25505215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Navigating Diagnostic and Treatment Decisions in Non-Small Cell Lung Cancer: Expert Commentary on the Multidisciplinary Team Approach.
    Popat S; Navani N; Kerr KM; Smit EF; Batchelor TJP; Van Schil P; Senan S; McDonald F
    Oncologist; 2021 Feb; 26(2):e306-e315. PubMed ID: 33145902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stage III Non-small Cell Lung Cancer: A UK National Survey of Practice.
    Evison M; Edwards J; McDonald F; Popat S
    Clin Oncol (R Coll Radiol); 2020 Aug; 32(8):527-536. PubMed ID: 32216979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of Early-Stage Resected Non-Small Cell Lung Cancer: Consensus Statement of the Lung cancer Consortium.
    Allehebi A; Kattan KA; Rujaib MA; Dayel FA; Black E; Mahrous M; AlNassar M; Hussaini HA; Twairgi AA; Abdelhafeiz N; Omair AA; Shehri SA; Al-Shamsi HO; Jazieh AR
    Cancer Treat Res Commun; 2022; 31():100538. PubMed ID: 35220069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of adjuvant chemotherapy (CT) and radiotherapy (RT) in incompletely resected (R1) early stage Non-Small Cell Lung Cancer (NSCLC): a European survey conducted by the European Society for Medical Oncology (ESMO) young oncologists committee.
    Califano R; Karamouzis MV; Banerjee S; de Azambuja E; Guarneri V; Hutka M; Jordan K; Kamposioras K; Martinelli E; Corral J; Postel-Vinay S; Preusser M; Porcu L; Torri V
    Lung Cancer; 2014 Jul; 85(1):74-80. PubMed ID: 24746176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment patterns and real-world evidence for stage III non-small cell lung cancer in Central and Eastern Europe.
    Zemanova M; Jakopovic M; Stanic K; Łazar-Poniatowska M; Vrankar M; Rusu P; Ciuleanu T; Radosavljevic D; Bogos K; Nawrocki S
    Radiol Oncol; 2020 Oct; 54(4):447-454. PubMed ID: 33048837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter survey of first-line treatment patterns and gene aberration test status of patients with unresectable Stage IIIB/IV nonsquamous non-small cell lung cancer in China (CTONG 1506).
    Zhou Q; Song Y; Zhang X; Chen GY; Zhong DS; Yu Z; Yu P; Zhang YP; Chen JH; Hu Y; Feng GS; Song X; Shi Q; Yang LL; Zhang PH; Wu YL
    BMC Cancer; 2017 Jul; 17(1):462. PubMed ID: 28673332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The current treatment landscape in the UK for stage III NSCLC.
    Evison M;
    Br J Cancer; 2020 Dec; 123(Suppl 1):3-9. PubMed ID: 33293670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining oligometastatic non-small cell lung cancer: A simulated multidisciplinary expert opinion.
    Hendriks LEL; Dooms C; Berghmans T; Novello S; Levy A; De Ruysscher D; Hasan B; Giaj Levra M; Giaj Levra N; Besse B; Vansteenkiste J; Dingemans AC;
    Eur J Cancer; 2019 Dec; 123():28-35. PubMed ID: 31655358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic and therapeutic approaches to lung cancer in Canada and their costs.
    Evans WK; Will BP; Berthelot JM; Wolfson MC
    Br J Cancer; 1995 Nov; 72(5):1270-7. PubMed ID: 7577481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of elderly patients with NSCLC; updated expert's opinion paper: EORTC Elderly Task Force, Lung Cancer Group and International Society for Geriatric Oncology.
    Pallis AG; Gridelli C; Wedding U; Faivre-Finn C; Veronesi G; Jaklitsch M; Luciani A; O'Brien M
    Ann Oncol; 2014 Jul; 25(7):1270-1283. PubMed ID: 24638905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.